International Business Machines Corporation IBM
Verdict: Sell. Fair value $146 against a price of $295 on 6 Jan 2026, 51% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Net Income shows extreme volatility, dropping from $5.74B in 2021 to $1.64B in 2022, before....
Main risks
- High Leverage: The Debt-to-Equity ratio of 2.14 is elevated, increasing financial risk and making earnings more sensitive to business cycle fluctuations.
- Volatile Net Income: Annual net income has been highly inconsistent ($5.7B in 2021, $1.6B in 2022, $7.5B in 2023), suggesting poor earnings quality or the impact of significant one-off items.
- Decelerating Revenue Growth: Annual revenue growth has slowed from 5.5% (2021-2022) to 1.4% (2023-2024), indicating challenges in maintaining momentum in a competitive tech landscape.
- Net Income shows extreme volatility, dropping from $5.74B in 2021 to $1.64B in 2022, before...
- Intense competitive environment
- Net Income shows extreme volatility, dropping from $5.74B in 2021 to $1.64B in 2022, before rebounding to $7.50B in 2023. This swing of nearly $6B is not reflected in the more stable Operating Cash Flow ($12.80B -> $10.44B -> $13.93B), indicating that large, non-cash, non-recurring items are significantly impacting reported earnings and reducing their reliability for trend analysis.